Is KELA - Kempisch Laboratorium - Kela Laboratoria still active?

Yes, KELA - Kempisch Laboratorium - Kela Laboratoria is currently active.

What does KELA - Kempisch Laboratorium - Kela Laboratoria do?

KELA - Kempisch Laboratorium - Kela Laboratoria's registered main activities are Manufacture of medicaments, Manufacture of veterinary preparations, Manufacture of diverse medicaments, including homeopathic preparations, and Systematic studies and creative efforts undertaken in various types of math research and development and natural sciences (physics, astronomy, chemistry, medical sciences, biology, etc.).

Where is KELA - Kempisch Laboratorium - Kela Laboratoria registered?

KELA - Kempisch Laboratorium - Kela Laboratoria's registered address is Sint Lenaartseweg 48, 2320 Hoogstraten, Belgium.

How many employees does KELA - Kempisch Laboratorium - Kela Laboratoria have?

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2025), KELA - Kempisch Laboratorium - Kela Laboratoria reported 261.4 full-time equivalent employees.

What is KELA - Kempisch Laboratorium - Kela Laboratoria's annual turnover?

KELA - Kempisch Laboratorium - Kela Laboratoria's most recently filed annual turnover (fiscal year ending 31 Dec 2025) was €55,218,027.

Did KELA - Kempisch Laboratorium - Kela Laboratoria make a profit or a loss?

KELA - Kempisch Laboratorium - Kela Laboratoria's most recently filed annual accounts (fiscal year ending 31 Dec 2025) reported a loss of €1,194,162.

When did KELA - Kempisch Laboratorium - Kela Laboratoria last file annual accounts?

KELA - Kempisch Laboratorium - Kela Laboratoria's most recently filed annual accounts cover the fiscal year ending 31 Dec 2025.

Is KELA - Kempisch Laboratorium - Kela Laboratoria B Corp certified?

We have no B Corp certification on file for KELA - Kempisch Laboratorium - Kela Laboratoria.

Does KELA - Kempisch Laboratorium - Kela Laboratoria hold Fairtrade certification?

No, KELA - Kempisch Laboratorium - Kela Laboratoria does not currently hold Fairtrade certification.

KELA - Kempisch Laboratorium - Kela Laboratoria

Q: When was KELA - Kempisch Laboratorium - Kela Laboratoria founded?

KELA - Kempisch Laboratorium - Kela Laboratoria was founded on 15 Jul 1941, making it 85 years old.

BE 0403.835.645

Copied!

NV/SA

Status

Active

Founded

15 Jul 1941 · 85 yrs

Size

Large · 261.4 FTE

Abbreviation

Kela

Main activity

Manufacture of medicaments

Activities

4 activities

Manufacture of medicamentsManufacture of veterinary preparationsManufacture of diverse medicaments, including homeopathic preparationsSystematic studies and creative efforts undertaken in various types of math research and development and natural sciences (physics, astronomy, chemistry, medical sciences, biology, etc.)

Financials

Turnover2025

€55.2M+8.9%

Profit / Loss2025

−€1.2M-105%

Equity2025

€31.9M-3.6%

2025	2024	2023	2022
€55,218,027+8.9%	€50,685,866+7.8%	€47,005,254-0.4%	€47,219,311
-€1,194,162-105%	€23,751,179>1000%	-€2,241,122-289.3%	-€575,663
€31,935,337-3.6%	€33,129,498+239.9%	€9,748,399-18.7%	€11,989,521
€31,249,707+6.6%	€29,315,504-33.3%	€43,949,040+10.4%	€39,793,554
€1,370,407-82.7%	€7,909,507+282.3%	€2,069,036+116.1%	€957,588
261.4+3%	253.8+0.6%	252.3+2.7%	245.6
€211,240+5.8%	€199,708+7.2%	€186,307-3.1%	€192,261

Frequently asked questions

01What is KELA - Kempisch Laboratorium - Kela Laboratoria's official registered name?

KELA - Kempisch Laboratorium - Kela Laboratoria.

02What is KELA - Kempisch Laboratorium - Kela Laboratoria's enterprise number (VAT number)?

BE 0403.835.645.

03What is KELA - Kempisch Laboratorium - Kela Laboratoria's legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

Financial statements

	2025	2024	2023	2022
Income statement
	€55,218,027+8.9%	€50,685,866+7.8%	€47,005,254-0.4%	€47,219,311
	261.4+3%	253.8+0.6%	252.3+2.7%	245.6
	€211,240+5.8%	€199,708+7.2%	€186,307-3.1%	€192,261
	€20,378,933+5.7%	€19,289,977+4.9%	€18,382,481+7.7%	€17,075,724
	-€746,356-133.1%	€2,255,069+307.4%	-€1,087,198+49%	-€2,131,629
	€1,810,943-57.8%	€4,290,047+297.7%	€1,078,682+755.7%	-€164,517
	—	—	-€84,210-106.1%	€1,378,481
	-€1,194,162-105%	€23,751,179>1000%	-€2,241,122-289.3%	-€575,663
	€270,027+61.2%	€167,503+33.2%	€125,756-13.1%	€144,803
Profitability
	3.3%-61.2%	8.5%+268.8%	2.3%+758.7%	-0.3%
	-2.2%-104.6%	46.9%>1000%	-4.8%-291.1%	-1.2%
	-3.7%-105.2%	71.7%+411.8%	-23.0%-378.8%	-4.8%
	-1.9%-105%	38.0%>1000%	-4.2%-275.5%	-1.1%
Solvency
	€63,185,043+1.2%	€62,445,003+16.3%	€53,697,440+3.7%	€51,792,043
	€20,519,394+6.5%	€19,268,900+3.8%	€18,565,571-3.7%	€19,276,032
	€8,338,6340%	€8,337,737-13.1%	€9,600,635+0.1%	€9,592,818
	€31,935,337-3.6%	€33,129,498+239.9%	€9,748,399-18.7%	€11,989,521
	50.5%-4.7%	53.1%+192.2%	18.2%-21.6%	23.1%
	€9,066,078+8.5%	€8,356,813+1.5%	€8,233,295-12.9%	€9,455,799
	0.28+12.5%	0.25-70.1%	0.84+7.1%	0.79
	€31,249,707+6.6%	€29,315,504-33.3%	€43,949,040+10.4%	€39,793,554
	0.98+10.6%	0.88-80.4%	4.51+35.8%	3.32
	-1.85-213.9%	1.62+265.6%	-0.98+70.6%	-3.33
Liquidity
	€1,370,407-82.7%	€7,909,507+282.3%	€2,069,036+116.1%	€957,588
	€14,458,016+15.8%	€12,487,041+30.3%	€9,581,496-20.4%	€12,038,090
	€14,468,874+27.8%	€11,319,607-8.8%	€12,412,818+46.8%	€8,456,237
	€7,249,191-4.3%	€7,572,538+28.3%	€5,903,818+4.2%	€5,667,328
	€21,576,142+6.1%	€20,332,767-42.5%	€35,352,422+17.7%	€30,035,925
	1.40+15.1%	1.22+87.7%	0.65-9.7%	0.72
	€10,203,981-17.9%	€12,422,461+218.1%	-€10,522,107-37.9%	-€7,632,484
Efficiency
	96 days+17.3%	82 days-15.4%	96 days+47.5%	65 days
	74 days-17.6%	90 days+22.4%	74 days+16.6%	63 days
	224 days+1.8%	220 days+23.9%	178 days-11.7%	201 days
	1.75-6.9%	1.88+3.3%	1.82-5.7%	1.93
Profit appropriation
	€965,1850%	€965,185+71.2%	€563,8410%	€563,841
	€22,041,814-5.1%	€23,235,976>1000%	-€113,859-105.3%	€2,127,263

Sources

NBB — Nationale Bank van België

	2025	2024	2023	2022
Income statement
	€55,218,027+8.9%	€50,685,866+7.8%	€47,005,254-0.4%	€47,219,311
	261.4+3%	253.8+0.6%	252.3+2.7%	245.6
	€211,240+5.8%	€199,708+7.2%	€186,307-3.1%	€192,261
	€20,378,933+5.7%	€19,289,977+4.9%	€18,382,481+7.7%	€17,075,724
	-€746,356-133.1%	€2,255,069+307.4%	-€1,087,198+49%	-€2,131,629
	€1,810,943-57.8%	€4,290,047+297.7%	€1,078,682+755.7%	-€164,517
	—	—	-€84,210-106.1%	€1,378,481
	-€1,194,162-105%	€23,751,179>1000%	-€2,241,122-289.3%	-€575,663
	€270,027+61.2%	€167,503+33.2%	€125,756-13.1%	€144,803
Profitability
	3.3%-61.2%	8.5%+268.8%	2.3%+758.7%	-0.3%
	-2.2%-104.6%	46.9%>1000%	-4.8%-291.1%	-1.2%
	-3.7%-105.2%	71.7%+411.8%	-23.0%-378.8%	-4.8%
	-1.9%-105%	38.0%>1000%	-4.2%-275.5%	-1.1%
Solvency
	€63,185,043+1.2%	€62,445,003+16.3%	€53,697,440+3.7%	€51,792,043
	€20,519,394+6.5%	€19,268,900+3.8%	€18,565,571-3.7%	€19,276,032
	€8,338,6340%	€8,337,737-13.1%	€9,600,635+0.1%	€9,592,818
	€31,935,337-3.6%	€33,129,498+239.9%	€9,748,399-18.7%	€11,989,521
	50.5%-4.7%	53.1%+192.2%	18.2%-21.6%	23.1%
	€9,066,078+8.5%	€8,356,813+1.5%	€8,233,295-12.9%	€9,455,799
	0.28+12.5%	0.25-70.1%	0.84+7.1%	0.79
	€31,249,707+6.6%	€29,315,504-33.3%	€43,949,040+10.4%	€39,793,554
	0.98+10.6%	0.88-80.4%	4.51+35.8%	3.32
	-1.85-213.9%	1.62+265.6%	-0.98+70.6%	-3.33
Liquidity
	€1,370,407-82.7%	€7,909,507+282.3%	€2,069,036+116.1%	€957,588
	€14,458,016+15.8%	€12,487,041+30.3%	€9,581,496-20.4%	€12,038,090
	€14,468,874+27.8%	€11,319,607-8.8%	€12,412,818+46.8%	€8,456,237
	€7,249,191-4.3%	€7,572,538+28.3%	€5,903,818+4.2%	€5,667,328
	€21,576,142+6.1%	€20,332,767-42.5%	€35,352,422+17.7%	€30,035,925
	1.40+15.1%	1.22+87.7%	0.65-9.7%	0.72
	€10,203,981-17.9%	€12,422,461+218.1%	-€10,522,107-37.9%	-€7,632,484
Efficiency
	96 days+17.3%	82 days-15.4%	96 days+47.5%	65 days
	74 days-17.6%	90 days+22.4%	74 days+16.6%	63 days
	224 days+1.8%	220 days+23.9%	178 days-11.7%	201 days
	1.75-6.9%	1.88+3.3%	1.82-5.7%	1.93
Profit appropriation
	€965,1850%	€965,185+71.2%	€563,8410%	€563,841
	€22,041,814-5.1%	€23,235,976>1000%	-€113,859-105.3%	€2,127,263

2025

2024

2023

2022

Income statement

€55,218,027+8.9%

€50,685,866+7.8%

€47,005,254-0.4%

€47,219,311

261.4+3%

253.8+0.6%

252.3+2.7%

245.6

€211,240+5.8%

€199,708+7.2%

€186,307-3.1%

€192,261

€20,378,933+5.7%

€19,289,977+4.9%

€18,382,481+7.7%

€17,075,724

-€746,356-133.1%

€2,255,069+307.4%

-€1,087,198+49%

-€2,131,629

€1,810,943-57.8%

€4,290,047+297.7%

€1,078,682+755.7%

-€164,517

—

-€84,210-106.1%

€1,378,481

-€1,194,162-105%

€23,751,179>1000%

-€2,241,122-289.3%

-€575,663

€270,027+61.2%

€167,503+33.2%

€125,756-13.1%

€144,803

Profitability

3.3%-61.2%

8.5%+268.8%

2.3%+758.7%

-0.3%

-2.2%-104.6%

46.9%>1000%

-4.8%-291.1%

-1.2%

-3.7%-105.2%

71.7%+411.8%

-23.0%-378.8%

-4.8%

-1.9%-105%

38.0%>1000%

-4.2%-275.5%

-1.1%

Solvency

€63,185,043+1.2%

€62,445,003+16.3%

€53,697,440+3.7%

€51,792,043

€20,519,394+6.5%

€19,268,900+3.8%

€18,565,571-3.7%

€19,276,032

€8,338,6340%

€8,337,737-13.1%

€9,600,635+0.1%

€9,592,818

€31,935,337-3.6%

€33,129,498+239.9%

€9,748,399-18.7%

€11,989,521

50.5%-4.7%

53.1%+192.2%

18.2%-21.6%

23.1%

€9,066,078+8.5%

€8,356,813+1.5%

€8,233,295-12.9%

€9,455,799

0.28+12.5%

0.25-70.1%

0.84+7.1%

0.79

€31,249,707+6.6%

€29,315,504-33.3%

€43,949,040+10.4%

€39,793,554

0.98+10.6%

0.88-80.4%

4.51+35.8%

3.32

-1.85-213.9%

1.62+265.6%

-0.98+70.6%

-3.33

Liquidity

€1,370,407-82.7%

€7,909,507+282.3%

€2,069,036+116.1%

€957,588

€14,458,016+15.8%

€12,487,041+30.3%

€9,581,496-20.4%

€12,038,090

€14,468,874+27.8%

€11,319,607-8.8%

€12,412,818+46.8%

€8,456,237

€7,249,191-4.3%

€7,572,538+28.3%

€5,903,818+4.2%

€5,667,328

€21,576,142+6.1%

€20,332,767-42.5%

€35,352,422+17.7%

€30,035,925

1.40+15.1%

1.22+87.7%

0.65-9.7%

0.72

€10,203,981-17.9%

€12,422,461+218.1%

-€10,522,107-37.9%

-€7,632,484

Efficiency

96 days+17.3%

82 days-15.4%

96 days+47.5%

65 days

74 days-17.6%

90 days+22.4%

74 days+16.6%

63 days

224 days+1.8%

220 days+23.9%

178 days-11.7%

201 days

1.75-6.9%

1.88+3.3%

1.82-5.7%

1.93

Profit appropriation

€965,1850%

€965,185+71.2%

€563,8410%

€563,841

€22,041,814-5.1%

€23,235,976>1000%

-€113,859-105.3%

€2,127,263

KELA - Kempisch Laboratorium - Kela Laboratoria

Activities

Financials

Frequently asked questions

All locations

Financial statements

All locations

Financial statements